What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
The scientist’s investigation covers issues in Breast cancer, Pathology, Internal medicine, Oncology and Cancer.
His studies link Cancer research with Breast cancer.
His studies in Pathology integrate themes in fields like Basal and Molecular pathology.
His research integrates issues of Endocrinology and Surgery in his study of Internal medicine.
His Oncology research is multidisciplinary, incorporating perspectives in Multivariate analysis, Lymph node, Stage, Survival analysis and Adjuvant therapy.
The Mammary gland study combines topics in areas such as Epidermal growth factor and Pathological.
His most cited work include:
- Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. (4800 citations)
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups (3323 citations)
- Pathological prognostic factors in breast cancer. (1611 citations)
What are the main themes of his work throughout his whole career to date?
Breast cancer, Internal medicine, Pathology, Oncology and Cancer research are his primary areas of study.
His Breast cancer research integrates issues from Immunohistochemistry and Tissue microarray.
His research ties Endocrinology and Internal medicine together.
Ian O. Ellis usually deals with Pathology and limits it to topics linked to Ductal carcinoma and Radiology.
His Oncology study combines topics in areas such as Gynecology, Metastasis, Proportional hazards model, Biomarker and Survival analysis.
His biological study spans a wide range of topics, including Cancer cell, Immunology and DNA repair.
He most often published in these fields:
- Breast cancer (68.84%)
- Internal medicine (40.15%)
- Pathology (38.41%)
What were the highlights of his more recent work (between 2016-2021)?
- Breast cancer (68.84%)
- Internal medicine (40.15%)
- Oncology (34.74%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Breast cancer, Internal medicine, Oncology, Immunohistochemistry and Cancer research.
Breast cancer is the subject of his research, which falls under Cancer.
In his research on the topic of Oncology, Androgen receptor is strongly related with Triple-negative breast cancer.
His work carried out in the field of Cancer research brings together such families of science as Cancer cell, Immunology, Messenger RNA, Disease and DNA repair.
His Tissue microarray study integrates concerns from other disciplines, such as Subclass and Risk factor.
His Pathology study combines topics from a wide range of disciplines, such as Ductal carcinoma, Transcriptome, Metastasis and Tumor-infiltrating lymphocytes.
Between 2016 and 2021, his most popular works were:
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (270 citations)
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (241 citations)
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial (193 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Ian O. Ellis mainly investigates Breast cancer, Internal medicine, Oncology, Cancer research and Immunohistochemistry.
His Breast cancer research is multidisciplinary, relying on both Carcinoma, Cohort and Pathology.
He has researched Internal medicine in several fields, including Fusion gene, Biological evolution and MEDLINE.
His Oncology research incorporates themes from Human Epidermal Growth Factor Receptor 2, Tumour heterogeneity and Lymph node.
Ian O. Ellis combines subjects such as Cell growth, Cyclin E and Messenger RNA, Gene, DNA repair with his study of Cancer research.
Ian O. Ellis has included themes like Biomarker, Low protein, Triple-negative breast cancer and GPER in his Immunohistochemistry study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
